Vicarious Surgical (RBOT) Non-Current Debt (2021 - 2022)
Vicarious Surgical (RBOT) posted quarterly Non-Current Debt of $250000.0 for Q3 2022, down 70.1% year-over-year from $836000.0 in Q3 2021, and down 36.22% quarter-over-quarter from $392000.0 in Q2 2022.
Vicarious Surgical (RBOT) Non-Current Debt (2021 - 2022) Analysis & Trends
Vicarious Surgical (RBOT) has reported Non-Current Debt for 2 consecutive years, with $250000.0 the latest figure, recorded in Q3 2022.
- In Q3 2022, Non-Current Debt fell 70.1% year-over-year to $250000.0; the TTM figure through Sep 2022 stood at $250000.0 (down 70.1% YoY), while the FY2021 annual figure was $675000.0, changed N/A from the prior year.
- Non-Current Debt slipped to $250000.0 in Q3 2022 per RBOT's latest filing, from $392000.0 in the prior quarter.
- Across five years, Non-Current Debt topped out at $836000.0 in Q3 2021 and bottomed at $250000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.65 Bn |
| 10 | Vicarious Surgical | 196,495.36 | -14.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 250,000.00 |
| Jun 30, 2022 | 392,000.00 |
| Mar 31, 2022 | 534,000.00 |
| Dec 31, 2021 | 675,000.00 |
| Sep 30, 2021 | 836,000.00 |